The DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index.
BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.
Open accessAbstract
We report the identities of the members of a group of proteins that associate with BRCA1 to form a large complex that we have named BASC (B RCA1-a ssociated genome s urveillance c omplex). This complex includes tumor suppressors and DNA damage repair proteins MSH2, MSH6, MLH1, ATM, BLM, and the RAD50–MRE11–NBS1 protein complex. In addition, DNA replication factor C (RFC), a protein complex that facilitates the loading of PCNA onto DNA, is also part of BASC. We find that BRCA1, the BLM helicase, and the RAD50–MRE11–NBS1 complex colocalize to large nuclear foci that contain PCNA when cells are treated with agents that interfere with DNA synthesis. The association of BRCA1 with MSH2 and MSH6, which are required for transcription-coupled repair, provides a possible explanation for the role of BRCA1 in this pathway. Strikingly, all members of this complex have roles in recognition of abnormal DNA structures or damaged DNA, suggesting that BASC may serve as a sensor for DNA damage. Several of these proteins also have roles in DNA replication-associated repair. Collectively, these results suggest that BRCA1 may function as a coordinator of multiple activities required for maintenance of genomic integrity during the process of DNA replication and point to a central role for BRCA1 in DNA repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to ATM, the members of the BASC include the mismatch repair proteins, MLH1, MSH2, and MSH6, the Bloom's syndrome helicase (BLM), and the Mre11-Rad50-NBS1 complex.”
From Cell cycle checkpoint signaling through the ATM and ATR kinases (2001) · cites this paper as Wang et al. 2000
In the citing paper
“Recent findings position ATM and ATR as critical upstream modulators of the breast cancer susceptibility protein, BRCA1”
From Cell cycle checkpoint signaling through the ATM and ATR kinases (2001) · cites this paper as Wang et al. 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496
RetractedA Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
The Bloom's syndrome gene product is homologous to RecQ helicases
Ellis, N. A., Groden, J. L., Ye, T.-Z., Straughen, J. E., Lennon, D. J., Ciocci, S., Proytcheva, M. A., & GERMAN, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90105-1 · Cited by 1,385
BRCA1 mutations in primary breast and ovarian carcinomas.
Futreal, P., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L., Haugen-Strano, A., Swensen, J., & Miki, Y. (1994) · Science · doi:10.1126/science.7939630 · Cited by 1,378
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322
Flagged first, then by citations
2 of the 54 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 1,000
Regulation of RelA (p65) Function by the Large Subunit of Replication Factor C
Anderson, L. A., & Perkins, N. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.721-732.2003 · Cited by 26
Gossage, L., & Madhusudan, S. (2007) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256260 · Cited by 26
3R coordination by Fanconi anemia proteins
Macé‐Aimé, G., Bogliolo, M., Guervilly, J.-H., du Villard, J.-A. D., & Rosselli, F. (2005) · Biochimie · doi:10.1016/j.biochi.2005.05.003 · Cited by 26
Dhh1 regulates the G1/S-checkpoint following DNA damage or BRCA1 expression in yeast1
Westmoreland, T. J., Olson, J. A., Saito, W. Y., Hüper, G., Marks, J. R., & Bennett, C. B. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00155-0 · Cited by 26
Angèle, S., Jones, C., Filho, J. S. R., Fulford, L. G., Treilleux, I., Lakhani, S. R., & Hall, J. A. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.017434 · Cited by 26
Maresca, L., Lodovichi, S., Lorenzoni, A., Cervelli, T., Monaco, R., Spugnesi, L., Tancredi, M., Falaschi, E., Zavaglia, K. M., Landucci, E., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00397 · Cited by 25
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
Petrelli, A., Rizzolio, S., Pietrantonio, F., Bellomo, S. E., Benelli, M., Cecco, L. D., Romagnoli, D., Berrino, E., Orrù, C., Ribisi, S., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2620 · Cited by 25
The regulation of CHK2 in human cancer
Craig, A. L., & Hupp, T. R. (2004) · Oncogene · doi:10.1038/sj.onc.1208035 · Cited by 25
Chiu, A. O. S., Katz, A. J., Beaubier, J., Chiu, N. H., & Shi, X. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000007274.25052.82 · Cited by 25
The function of RecQ helicase gene family (especially BLM) in DNA recombination and joining
Kaneko, H., Fukao, T., & Kondo, N. (2004) · Advances in Biophysics · doi:10.1016/s0065-227x(04)80061-3 · Cited by 25
Warmoes, M. O., Jaspers, J. E., Pham, T. V., Piersma, S. R., Oudgenoeg, G., Massink, M. P. G., Waisfisz, Q., Rottenberg, S., Boven, E., Jonkers, J., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.013334 · Cited by 26
Kim, Y. R., Song, S. Y., Kim, S. S., An, C. H., Lee, S. H., & Yoo, N. J. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.03.006 · Cited by 25
Déry, U., & Masson, J. (2007) · DNA repair · doi:10.1016/j.dnarep.2006.12.009 · Cited by 27
Recombination: Mechanisms and Roles in Tumorigenesis
Nickoloff, J. A. (2002) · Elsevier eBooks · doi:10.1016/b0-12-227555-1/00201-x · Cited by 25
Homologous Recombination Repair Gene Mutations in Prostate Cancer: Prevalence and Clinical Value
Yu, F., Liu, Z., Chen, Y., & He, Z. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02844-7 · Cited by 26
Biomarkers in high grade serous ovarian cancer
Bates, M., Mohamed, B. M., Lewis, F., O’Toole, S. A., & O’Leary, J. J. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189224 · Cited by 24
ATM and Cellular Response to DNA Damage
Lavin, M. F., Kozlov, S., Gueven, N., Peng, C., Birrell, G. W., Chen, P., & Scott, S. P. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_16 · Cited by 24
Interaction between human mismatch repair recognition proteins and checkpoint sensor Rad9-Rad1-Hus1
Bai, H., Madabushi, A., Guan, X., & Lu, A.-L. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.01.011 · Cited by 25
Suppression of BRCA1 sensitizes cells to proteasome inhibitors
Gu, Y., Bouwman, P., Greco, D., Saarela, J., Yadav, B., Jonkers, J., & Kuznetsov, S. G. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.537 · Cited by 24
DNA Damage Response Mediated through BRCA1
Jang, E. R., & Lee, J. (2004) · Cancer Research and Treatment · doi:10.4143/crt.2004.36.4.214 · Cited by 24
BRCA1/2 genetic background-based therapeutic tailoring of human ovarian cancer: hope or reality?
Tagliaferri, P., Ventura, M., Baudi, F., Cucinotto, I., Arbitrio, M., Martino, M. T. D., & Tassone, P. (2009) · Journal of Ovarian Research · doi:10.1186/1757-2215-2-14 · Cited by 24
Shi, J., Chen, W., Zhang, B., Fan, S., Ai, X., Liu, N.-N., Réty, S., & Xi, X. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.761510 · Cited by 24
Dokal, I. S. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200215 · Cited by 24
Small Molecule Modulation of the Human Chromatid Decatenation Checkpoint
Haggarty, S. J., Koeller, K. M., Kau, T. R., Silver, P. A., Roberge, M., & Schreiber, S. L. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.11.014 · Cited by 24
Yra1 Is Required for S Phase Entry and Affects Dia2 Binding to Replication Origins
Swaminathan, S., Kile, A. C., MacDonald, E. M., & Koepp, D. M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02052-06 · Cited by 24
Complex-based analysis of dysregulated cellular processes in cancer
Srihari, S., Madhamshettiwar, P. B., Song, S., Liu, C., Simpson, P. T., Khanna, K. K., & Ragan, M. A. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-s4-s1 · Cited by 25
Golla, U., Singh, V., Azad, G. K., Singh, P. K., Verma, N., Mandal, P., Chauhan, S., & Tomar, R. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064798 · Cited by 23
Mechanisms used by DNA MMR system to cope with Cadmium-induced DNA damage in plants
Wang, H., Cao, Q., Zhao, Q., Arfan, M., & Liu, W. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.125614 · Cited by 23
DNA Damage and Polyploidization
Chow, J. P. H., & Poon, R. Y. C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6199-0_4 · Cited by 24
Jascur, T. A., Fotedar, R., Greene, S., Hotchkiss, E. C., & Boland, C. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.221341 · Cited by 23
Zhang, L., Chen, H., Gong, M., & Gong, F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00007 · Cited by 24
Chromosome Breakage Is Regulated by the Interaction of the BLM Helicase and Topoisomerase IIα
Russell, B., Bhattacharyya, S., Keirsey, J. K., Sandy, A., Grierson, P. M., Perchiniak, E. M., Kavecansky, J., Acharya, S., & Groden, J. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1727 · Cited by 23
Rübben, A., Wahl, R. U., Eggermann, T., Dahl, E., Ortiz‐Brüchle, N., & Cacchi, C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230003 · Cited by 23
García‐Campelo, R., Curbera, G. A.-J., Aparicio, L. M. A., & Rosell, R. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.12.2015 · Cited by 23
Development of therapeutic approaches to ‘triple negative’ phenotype breast cancer
Shiu, K., Tan, D. S. P., & Reis-Filho, J. S. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.9.1123 · Cited by 23
Naseem, R., Sturdy, A., Finch, D., Jowitt, T. A., & Webb, M. (2006) · Biochemical Journal · doi:10.1042/bj20051646 · Cited by 23
RecQ helicases and genome stability: lessons from model organisms and human disease
Bjergbæk, L., Cobb, J., & Gasser, S. M. (2002) · Swiss Medical Weekly · doi:10.4414/smw.2002.09886 · Cited by 23
Romagnolo, D. F., Chirnomas, R. B., Ku, J., Jeffy, B. D., Payne, C. M., Holubec, H., Ramsey, L., Bernstein, H., Bernstein, C., Kunke, K., et al. (2003) · Nutrition and Cancer · doi:10.1207/s15327914nc4601_11 · Cited by 23
Clikeman, J. A., Wheeler, S. L., & Nickoloff, J. A. (2001) · Genetics · doi:10.1093/genetics/157.4.1481 · Cited by 23
Moquin, D., Genois, M., Zhang, J., Ouyang, J., Yadav, T., Buisson, R., Yazinski, S. A., Tan, J. J., Boukhali, M., Gagné, J., et al. (2018) · Genes & Development · doi:10.1101/gad.315978.118 · Cited by 23
Structural basis to characterise transactivation domain of BRCA1
Yadav, L. R., Biswal, M. N., Hosur, M. V., Kumar, N. S., & Varma, A. K. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2015.1136896 · Cited by 22
Impact of Physical Activity on Oxidative Stress Markers in Patients with Metastatic Breast Cancer
Delrieu, L., Touillaud, M. S., Pérol, O., Morelle, M., Martin, A., Friedenreich, C. M., Mury, P., Dufresne, A., Bachelot, T., Heudel, P., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6694594 · Cited by 22
BLM and RAD51 Genes Polymorphism and Susceptibility to Breast Cancer
Sassi, A., Popielarski, M., Synowiec, E., Morawiec, Z., & Woźniak, K. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9602-8 · Cited by 22
Genome-wide differential gene expression in immortalized DF-1 chicken embryo fibroblast cell line
Kong, B. C., Lee, J. Y., Bottje, W. G., Lassiter, K., Lee, J., & Foster, D. N. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-571 · Cited by 24
The Foci of DNA Double Strand Break-recognition Proteins Localize with γH2AX after Heat Treatment
Takahashi, A., Mori, E., & Ohnishi, T. (2010) · Journal of Radiation Research · doi:10.1269/jrr.09111 · Cited by 23
Trenz, K., Schütz, P., & Speit, G. (2005) · Mutagenesis · doi:10.1093/mutage/gei018 · Cited by 22
Turnover of BRCA1 Involves in Radiation-Induced Apoptosis
Liu, W., Zong, W., Wu, G. Y., Fujita, T., Li, W., Wu, J. Q., & Wan, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014484 · Cited by 24
Yoneshima, Y., Abolhassani, N., Iyama, T., Sakumi, K., Shiomi, N., Mori, M., Shiomi, T., Noda, T., Tsuchimoto, D., & Nakabeppu, Y. (2016) · Scientific Reports · doi:10.1038/srep32849 · Cited by 22
Selective Cleavage of BLM, the Bloom Syndrome Protein, during Apoptotic Cell Death
Bischof, O., Galande, S., Farzaneh, F., Kohwi-shigematsu, T., & Campisi, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006462200 · Cited by 22
RetractedBill, C. A., Taghian, D. G., Duran, W., & Nickoloff, J. A. (2001) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(01)00065-9 · Cited by 22
Independence of R/M/N Focus Formation and the Presence of Intact BRCA1
Wu, X., Petrini, J. H. J., Heine, W. F., Weaver, D. T., Livingston, D. M., & Chen, J. (2000) · Science · doi:10.1126/science.289.5476.11 · Cited by 23
Jain, M., Kaiser, R. W. J., Bohl, K., Hoehne, M., Göbel, H., Bartram, M. P., Habbig, S., Müller, R., Fogo, A. B., Benzing, T. R., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.10.034 · Cited by 24
Rakshit, S., Sunny, J. S., George, M., Hanna, L. E., & Sarkar, K. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101189 · Cited by 21
Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer
Summa, S. D., Pinto, R., Pilato, B., Sambiasi, D., Porcelli, L., Guida, G., Mattioli, E., Paradiso, A., Merla, G., Micale, L., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.30 · Cited by 21
ATM gene mutations in sporadic breast cancer patients from Brazil
Mangone, F. R., Miracca, E. C., Feilotter, H. E., Mulligan, L. M., & Nagai, M. A. (2015) · SpringerPlus · doi:10.1186/s40064-015-0787-z · Cited by 21
Parsa, F. G., Nobili, S., Karimpour, M., Aghdaei, H. A., Mojarad, E. N., & Mini, E. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030396 · Cited by 21
BRCA1 knock-down causes telomere dysfunction in mammary epithelial cells
Cabuy, E., Newton, C., & Slijepčević, P. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167820 · Cited by 21
The role of chromatin proteins in DNA damage recognition and repair Mini-review
Widłak, P., Pietrowska, M., & Łanuszewska, J. (2005) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0053-5 · Cited by 21
Defined factors to reactivate cell cycle activity in adult mouse cardiomyocytes
Judd, J., Lovas, J., & Huang, G. N. (2019) · Scientific Reports · doi:10.1038/s41598-019-55027-8 · Cited by 20
Li, M., Zhang, Q., Liu, L., Lu, W., Wei, H., Li, R., & Shen, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078500 · Cited by 20
Daniela Gerovska, D., Larrinaga, G., Solano-Iturri, J. D., Márquez, J., García-Gallastegui, P., Khatib, A., Poschmann, G., Stühler, K., Armesto, M., Lawrie, C. H., et al. (2020) · Cancers · doi:10.3390/cancers12092380 · Cited by 20
Nuclear antiviral innate responses at the intersection of DNA sensing and DNA repair
Justice, J. L., & Cristea, I. M. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.05.004 · Cited by 21
Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls
van Voss, M. R. H., van der Groep, P., Bart, J., van der Wall, E., & van Diest, P. J. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-145 · Cited by 20
Meyer, C., Brieger, A., Plotz, G., Weber, N., Passmann, S., Dingermann, T., Zeuzem, S., Trojan, J., & Marschalek, R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1908 · Cited by 20
Blocking protein quality control to counter hereditary cancers
Kampmeyer, C., Nielsen, S. V., Clausen, L., Stein, A., Gerdes, A., Lindorff‐Larsen, K., & Hartmann‐Petersen, R. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22487 · Cited by 21
Expression profiles and intergenic structure of head-to-head oriented Brca1 and Nbr1 genes
Dimitrov, S. D., Brennerova, M. V., & Forejt, J. (2001) · Gene · doi:10.1016/s0378-1119(00)00549-7 · Cited by 20
BRCA1 interactors, RAD50 and BRIP1, as prognostic markers for triple-negative breast cancer severity
Laha, S., Katheeja Muhseena, N., Das, R., & Das, R. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1035052 · Cited by 19
Naushad, S. M., Hussain, T., Al-Attas, O. S., Prayaga, A. K., Digumarti, R., Gottumukkala, S. R., & Kutala, V. K. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2037-z · Cited by 19
Synonymous Constraint Elements Show a Tendency to Encode Intrinsically Disordered Protein Segments
Macossay-Castillo, M., Kosol, S., Tompa, P., & Pancsa, R. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003607 · Cited by 21
DNA Repair System and Prostate Cancer Progression: The Role of NBS1 Polymorphism (rs1805794)
Silva, J., Teixeira, A. L., Lobo, F., Maurício, J., & Medeiros, R. (2012) · DNA and Cell Biology · doi:10.1089/dna.2011.1562 · Cited by 20
Characterizing methylation regulated miRNA in carcinoma of the human uterine cervix
Varghese, V. K., Shukla, V., Jishnu, P. V., Kabekkodu, S. P., Pandey, D., Sharan, K., & Satyamoorthy, K. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116668 · Cited by 19
Mammalian DNA Damage Response Pathway
Lou, Z., & Chen, J. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_15 · Cited by 19
The MRN-CtIP Pathway Is Required for Metaphase Chromosome Alignment
Rozier, L., Guo, Y., Peterson, S., Sato, M., Baer, R. J., Gautier, J., & Mao, Y. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.023 · Cited by 19
From NPC Therapeutic Target Identification to Potential Treatment Strategy
Lan, M., Chen, C., Lin, K., Lee, S., Yang, W.-L. R., Hsu, C.-N., Wu, J., Ho, C., Lin, J., & Huang, C. F. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0966 · Cited by 19
Association of rare MSH6 variants with familial breast cancer
Wasielewski, M., Riaz, M., Vermeulen, J., van den Ouweland, A., Labrijn-Marks, I., Olmer, R., van der Spaa, L., Klijn, J. G. M., Meijers-Heijboer, H. E. J., Dooijes, D., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0634-4 · Cited by 21
Becker, K., Goldberg, M., Helmbold, P., Holbach, L., Loeffler, K. U., & Ballhausen, W. G. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08783.x · Cited by 19
Chen, S., Paul, P., & Price, B. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206760 · Cited by 19
The Large Subunit of Replication Factor C Interacts with the Histone Deacetylase, HDAC1
Anderson, L. A., & Perkins, N. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200513200 · Cited by 19
Maguire, K., & Kmiec, E. B. (2006) · Gene · doi:10.1016/j.gene.2006.08.014 · Cited by 19
Kim, S. S., Cao, L., Baek, H. J., Lim, S., Li, C., Wang, R., Xu, X., Cho, K. H., & Deng, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2418 · Cited by 20
BRCA1 is required for hMLH1 stabilization following doxorubicin-induced DNA damage
Romeo, F., Falbo, L., Di Sanzo, M., Misaggi, R., Faniello, M. C., Viglietto, G., Cuda, G., Costanzo, F., & Quaresima, B. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.08.011 · Cited by 18
Tamaichi, H., Sato, M., Porter, A. C. G., Shimizu, T., Mizutani, S., & Takagi, M. (2012) · Cancer Science · doi:10.1111/cas.12067 · Cited by 18
Xu, J., Hu, L., Huang, M., Zhao, W., Yin, Y., Hu, Z., Ma, H., Shen, H., & Shu, Y. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.3.851 · Cited by 18
Ring chromosomes: vicious circles at the end and beginning of life
Gisselsson, D. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/37826 · Cited by 18
MutS homologue hMSH4: interaction with eIF3f and a role in NHEJ-mediated DSB repair
Chu, Y.-L., Wu, X., Xu, Y., & Her, C. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-51 · Cited by 19
Functional interactions between BLM and XRCC3 in the cell
Otsuki, M., Seki, M., Inoue, E., Yoshimura, A., Kato, G., Yamanouchi, S., Kawabe, Y.-I., Tada, S., Shinohara, A., Komura, J., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200702183 · Cited by 18
Expression of BRCA1, NBR1 and NBR2 Genes in Human Breast Cancer Cells
Dimitrov, S. D., Matoušková, E., & Forejt, J. (2001) · Folia Biologica · doi:10.14712/fb2001047040120 · Cited by 18
Kaufmann, W. K., Campbell, C. B., Simpson, D. A., Deming, P. B., Filatov, L. V., Galloway, D. A., Zhao, X. J., Creighton, A. M., & Downes, C. S. (2002) · Cell Cycle · doi:10.4161/cc.1.3.127 · Cited by 18
Hughes, D. J. (2008) · Familial Cancer · doi:10.1007/s10689-008-9181-0 · Cited by 18
Inhibition of Atm and/or Atr disrupts gene silencing on the inactive X chromosome
Ouyang, Y., Salstrom, J. L., Diaz-Perez, S. V., Nahas, S., Matsuno, Y., Dawson, D. W., Teitell, M. A., Horvath, S., Riggs, A. D., Gatti, R. A., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.122 · Cited by 19
Roles of RecQ Family Helicases in the Maintenance of Genome StabilityPreprint
Wu, L., Davies, S. L., & Hickson, I. D. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.573 · Cited by 18
BLM protein mitigates formaldehyde-induced genomic instability
Kumari, A. R., Owen, N. M., Juarez, E., & McCullough, A. K. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.02.010 · Cited by 17
Takahashi, T., Min, Z., Uchida, I., Arita, M., Watanabe, Y., Koi, M., & Hemmi, H. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.07.044 · Cited by 17
Trubicka, J., Żemojtel, T., Hecht, J., Falana, K., Piekutowska‐Abramczuk, D., Płoski, R., Perek‐Polnik, M., Drogosiewicz, M., Grajkowska, W., Ciara, E., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3211-y · Cited by 17
Cell biology of cancer: BRCA1 and sister chromatid pairing reactions?
Skibbens, R. V. (2008) · Cell Cycle · doi:10.4161/cc.7.4.5435 · Cited by 17
DNA Double Strand Break Repair and its Association with Inherited Predispositions to Breast Cancer
Scott, R. J. (2004) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-2-1-37 · Cited by 17
BRCA1 carries tumor suppressor activity distinct from that of p53 and p21
Randrianarison-Huetz, V., Marot, D., Foray, N., Cabannes, J., Méret, V., Connault, E., Vitrat, N., Opolon, P., Perricaudet, M., & Feunteun, J. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700366 · Cited by 17
Molecular Inhibitors of DNA Repair: Searching for the Ultimate Tumor Killing Weapon
Nikitaki, Z., Michalopoulos, I., & Georgakilas, A. G. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.95 · Cited by 16
Chromosome Instability in Patients with Chronic Renal Failure
Lialiaris, T. S., Mavromatidou, P., Digkas, E., Passadaki, T., Mpountoukas, P., Panagoutsos, S. A., & Vargemezis, V. A. (2009) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2009.0109 · Cited by 16
Analysis of the molecular mechanism of osteosarcoma using a bioinformatics approach
Jian-xun, Y., & Wang, N. (2016) · Oncology Letters · doi:10.3892/ol.2016.5060 · Cited by 16
Metadata
- Authors
- Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J.
- Affiliations
- New York Blood Center (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-04-15
- Volume
- 14
- Issue
- 8
- Pages
- 927-939
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC316544
- OpenAlex
- W2127566231
- Cited by
- 1,221
- References
- 54
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 16 · 2022: 21 · 2021: 27 · 2020: 20 · 2019: 26 · 2018: 20 · 2017: 24 · 2016: 29 · 2015: 33 · 2014: 49 · 2013: 43 · 2012: 35
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Jane Coffin Childs Memorial Fund for Medical Research
- U.S. Bureau of Land Management
- U.S. Public Health Service (Q1187)
- National Institute of General Medical Sciences (GM-44664, R37GM044664, R01GM044664)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BRCA1, BASC, DNA repair, MSH2, MSH6, MLH1, ATM, BLM helicase, PCNA, DNA damage recognition, genome stability, tumor suppressor proteins, nuclear foci
- MeSH terms
- Adenosine Triphosphatases, Cell Cycle, Cell Nucleus, DNA Repair, DNA Helicases, DNA-Binding Proteins, Endodeoxyribonucleases, Exodeoxyribonucleases, Fluorescent Antibody Technique, Fungal Proteins, HeLa Cells, Humans, Nuclear Proteins, Precipitin Tests, Protein Binding, Mass Spectrometry, Transcription, Genetic, Signal Transduction, Cell Cycle Proteins, BRCA1 Protein, Saccharomyces cerevisiae Proteins, Replication Protein C, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review